IMDX
Insight Molecular Diagnostics Inc. Common Stock
IMDX
IMDX
59 hedge funds and large institutions have $43.4M invested in Insight Molecular Diagnostics Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 26 increasing their positions, 14 reducing their positions, and 16 closing their positions.
Holders
59
Holders Change
-7
Holders Change %
-10.61%
% of All Funds
1.19%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
9
Increased
26
Reduced
14
Closed
16
Calls
$20K
Puts
–
Net Calls
+$20K
Net Calls Change
+$20K
Top Buyers
| 1 |
1
BlackRock
New York
|
$4.58M |
| 2 |
GCP
2
GSA Capital Partners
London,
United Kingdom
|
$279K |
| 3 |
3
Northern Trust
Chicago,
Illinois
|
$926K |
| 4 |
4
Goldman Sachs
New York
|
$241K |
| 5 |
5
Bank Julius Baer & Co
Zurich,
Switzerland
|
$375K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
Osaic Holdings
Scottsdale,
Arizona
| $0 | 330 | +50 | +18% |
|